Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Blood Advances|September 12, 2019
Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatmentIris de Weerdt, Tom Hofland, Renate de Boer, et al.
Cancer Research Communications|March 6, 2023
Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell LymphomasAnne W J Martens, Joanne M Rietveld, Renate de Boer, et al.
The Journal of Molecular Diagnostics : JMD|August 9, 2008
Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemiaShelly R Gunn, Mansoor S Mohammed, Mercedes E Gorre, et al.
Immunotherapy Advances|September 22, 2025
CD40L and IL-4 suppress NK cell-mediated antibody-dependent cellular cytotoxicity through the HLA-E:NKG2A axisLara V Graham, Ludmila Horehajova, Marco V Haselager, et al.
Molecular Oncology|November 18, 2022
SMG1, a nonsense-mediated mRNA decay (NMD) regulator, as a candidate therapeutic target in multiple myelomaAlexander C Leeksma, Ingrid A M Derks, Brett Garrick, et al.
Blood|May 29, 2016
Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemiaRachel Thijssen, Johanna Ter Burg, Brett Garrick, et al.
Blood|September 15, 2018
Improving CLL Vγ9Vδ2-T-cell fitness for cellular therapy by ex vivo activation and ibrutinibIris de Weerdt, Tom Hofland, Roeland Lameris, et al.
Nature Communications|January 25, 2025
Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLLLavinia Arseni, Gianluca Sigismondo, Haniyeh Yazdanparast, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 11, 2025
Disruption of constitutive CXCR4 oligomers impairs oncogenic properties in lymphoid neoplasmsSimon Mobach, Nick D Bergkamp, Ziliang Ma, et al.
European Journal of Immunology|July 17, 2015
Blimp-1 homolog Hobit identifies effector-type lymphocytes in humansFelipe A Vieira Braga, Kirsten M L Hertoghs, Natasja A M Kragten, et al.
Pageof 12